ICOS CORP 4
4 · ICOS CORP · Filed Jan 30, 2007
Insider Transaction Report
Form 4
ICOS CORPICOS
ST JOHN THOMAS P
VP, Therapeutic Development
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2007-01-29$16.94/sh−37,376$633,149→ 0 totalExercise: $17.06From: 1998-01-07Exp: 2008-01-07→ Common Stock (37,376 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-01-29$8.62/sh−26,200$225,844→ 0 totalExercise: $25.38From: 2005-01-27Exp: 2015-01-27→ Common Stock (26,200 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-01-29$6.00/sh−27,314$163,884→ 0 totalExercise: $28.00From: 1999-03-10Exp: 2009-03-10→ Common Stock (27,314 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-01-29$3.69/sh−25,963$95,739→ 0 totalExercise: $30.31From: 2000-01-05Exp: 2010-01-05→ Common Stock (25,963 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-01-29$9.11/sh−30,000$273,300→ 0 totalExercise: $24.89From: 2006-01-24Exp: 2016-01-23→ Common Stock (30,000 underlying) - Disposition to Issuer
Common Stock
2007-01-29$34.00/sh−9,272$315,248→ 0 total(indirect: By Spouse) - Disposition to Issuer
Common Stock
2007-01-29$34.00/sh−155,603$5,290,502→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2007-01-29$4.27/sh−60,300$257,481→ 0 totalExercise: $29.73From: 2002-12-10Exp: 2012-12-10→ Common Stock (60,300 underlying)
Footnotes (5)
- [F1]Disposed of pursuant to the Merger Agreement under which Eli Lilly and Company ("Eli Lilly") acquired the Issuer ("Merger") and which provides for the cancellation of shares of common stock of the Issuer in exchange for $34.00 per share (the "Merger Consideration). Includes 40,975 shares of unvested restricted stock.
- [F2]Disposed of pursuant to the Merger Agreement which provides for the cancellation of shares of common stock of the Issuer in exchange for the Merger Consideration.
- [F3]The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for the purposes of Section 16 or for any other purpose.
- [F4]The options vested monthly in 1/48th increments over four years (48 months) commencing on the grant date indicated.
- [F5]All options were cancelled pursuant to the Merger Agreement in exchange for cash consideration equal to the Merger Consideration less the exercise price per share.